E. Ernst et al., ADVERSE-EFFECTS PROFILE OF THE HERBAL ANTIDEPRESSANT ST.-JOHNS-WORT (HYPERICUM-PERFORATUM L.), European Journal of Clinical Pharmacology, 54(8), 1998, pp. 589-594
Objective: This paper provides a systematic review of adverse drug rea
ctions (ADRs) associated with the use of extracts of the herb St. John
's wort (Hypericum perforatum L.) for the treatment of mild to moderat
e depression. Methods: Searches of four computerized literature databa
ses were performed for records of (ADRs). Manufacturers of hypericum p
roducts. the international drug monitoring centre of the World Health
Organization (WHO) and the national drug safety monitoring bodies of G
ermany and the United Kingdom were also contacted for information. Res
ults: Information on (ADRs) originates from case reports. clinical tri
als, post-marketing surveillance and drug monitoring studies. Collecti
vely, the data suggest that hypericum is well tolerated? with an incid
ence of adverse reactions similar to that of placebo. The most common
adverse effects are gastrointestinal symptoms, dizziness/confusion and
tiredness/sedation. A potential serious adverse effect is photosensit
ivity, but this appears to occur extremely rarely. Conclusions: Hyperi
cum has an encouraging safety profile. However, as most of the current
data originate from short-term investigations, more long-term studies
are desirable.